TITLE:
A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving Prednisone

CONDITION:
Lung Disease

INTERVENTION:
interferon-gamma 1b

SUMMARY:

      Study GIPF-003 is a Phase 3b study designed to define better therapeutic use of IFN-gamma 1b
      in patients wtih IPF. The study will be conducted primarily in Europe and will enroll 210
      patients.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 20 Years to 79 Years
Criteria:
NONE
